We are live on ! Find out more
IART icon

Integra LifeSciences

147 hedge funds and large institutions have $1.24B invested in Integra LifeSciences in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 60 increasing their positions, 44 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 44

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

12% more call options, than puts

Call options by funds: $772K | Put options by funds: $691K

5% more capital invested

Capital invested by funds: $1.18B → $1.24B (+$61M)

2% more funds holding

Funds holding: 144147 (+3)

Holders
147
Holders Change
+3
Holders Change %
+2.08%
% of All Funds
4.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
60
Reduced
44
Closed
11
Calls
$772K
Puts
$691K
Net Calls
+$81K
Net Calls Change
-$296K
Name Holding Trade Value Shares
Change
Change in
Stake
OCM
51
Olstein Capital Management
New York
$2.59M +$274K +14,679 +12%
VAM
52
Visium Asset Management
New York
$2.57M +$2.49M +133,824 New
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
$2.51M +$91.2K +4,893 +4%
Public Sector Pension Investment Board (PSP Investments)
54
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.44M +$191K +10,238 +9%
ECP
55
Elk Creek Partners
Colorado
$2.4M +$2.33M +124,932 New
AllianceBernstein
56
AllianceBernstein
Tennessee
$2.27M +$63.8K +3,425 +3%
California State Teachers Retirement System (CalSTRS)
57
California State Teachers Retirement System (CalSTRS)
California
$2.15M +$182K +9,785 +10%
New York State Teachers Retirement System (NYSTRS)
58
New York State Teachers Retirement System (NYSTRS)
New York
$2.13M
KeyBank National Association
59
KeyBank National Association
Ohio
$2M +$114K +6,116 +6%
ACM
60
American Capital Management
New York
$1.98M
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$1.72M +$121K +6,490 +8%
TA
62
Teachers Advisors
New York
$1.65M +$37.7K +2,025 +2%
AIG
63
American International Group
New York
$1.53M +$44.6K +2,395 +3%
Two Sigma Investments
64
Two Sigma Investments
New York
$1.44M -$975K -52,343 -41%
FC
65
FIC Capital
New York
$1.38M +$1.34M +71,836 New
Citadel Advisors
66
Citadel Advisors
Florida
$1.37M +$367K +19,718 +38%
Susquehanna International Group
67
Susquehanna International Group
Pennsylvania
$1.32M +$1.28M +68,719 New
Swiss National Bank
68
Swiss National Bank
Switzerland
$1.26M
State Board of Administration of Florida Retirement System
69
State Board of Administration of Florida Retirement System
Florida
$1.23M +$130K +6,997 +12%
Two Sigma Advisers
70
Two Sigma Advisers
New York
$1.19M -$109K -5,871 -9%
TPSF
71
Texas Permanent School Fund
Texas
$1.13M +$6.97K +374 +0.6%
Comerica Bank
72
Comerica Bank
Texas
$1.11M -$14.2K -760 -1%
BG
73
BlackRock Group
United Kingdom
$1.09M -$86.7K -4,653 -8%
Morgan Stanley
74
Morgan Stanley
New York
$1.05M -$188K -10,101 -16%
FMT
75
First Mercantile Trust
Tennessee
$1.03M -$34.2K -1,835 -3%

IART Hedge Fund Activity: Q2 2014 in Review

147 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q2 2014, worth a combined $1.24B — up 5.2% from $1.18B a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new IART positions and 11 closed out — a net gain of 3 holders — while 60 added to existing stakes and 44 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $18.1M. The largest seller was Boston Partners, cutting an estimated $19.1M.

  • 147 institutional investors held Integra LifeSciences (IART) as of Q2 2014, up from 144 in Q1 2014.
  • Funds reported $1.24B of Integra LifeSciences stock for Q2 2014, up 5.2% quarter-over-quarter.
  • 14 funds opened new Integra LifeSciences positions in Q2 2014 and 11 closed out, a net change of +3 holders.
  • The largest Integra LifeSciences buyer in Q2 2014 was Goldman Sachs, an estimated $18.1M added.
  • The largest Integra LifeSciences seller in Q2 2014 was Boston Partners, an estimated $19.1M sold.

Based on aggregated 13F filings for Q2 2014.